IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#934
Positioning
Market Dominance
Services
Business Services
$29M
Wei Wen
TuanChe operates as an omni-channel automotive marketplace in China. It organizes auto shows and group-purchase events that attract various consumers. As of December 31, 2020, the company organized 499 auto shows in 172 cities across China. The company was founded in 2010 and is headquartered in Beijing, China.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = TC ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$YALA Yalla Group Ltd | 75 | 89 | 99 | 80 | - | - | 21.3% | 18.6% | 64.5% | 35.7% | 39.5% | 6.5% | 0.0% | 0.0x | $644M | VS | |
$GRVY GRAVITY Co., Ltd. | 75 | 82 | 96 | 71 | - | - | 15.4% | 12.6% | 38.7% | 17.1% | 17.0% | -39.7% | 0.0% | 0.0x | $439M | VS | |
$ISSC INNOVATIVE SOLUTIONS & SUPPORT INC | 73 | 81 | 88 | 94 | 25.0x | 14.1x | 28.1% | 16.8% | 48.1% | 23.8% | 18.5% | 78.6% | 0.0% | 37.0x | $220M | VS | |
$AER AerCap Holdings N.V. | 72 | 60 | 87 | 84 | - | - | 12.4% | 2.9% | 100.0% | 28.2% | 26.2% | 5.5% | 0.8% | 264.0x | $19.4B | VS | |
$HCSG HEALTHCARE SERVICES GROUP INC | 72 | 74 | 88 | 88 | 7.1x | 6.1x | 28.9% | 20.8% | 20.8% | 9.9% | 9.3% | 8.5% | 0.0% | 1.0x | $1.2B | VS | |
$LQDT LIQUIDITY SERVICES INC | 72 | 90 | 88 | 68 | 24.9x | 14.3x | 14.6% | 7.8% | 43.8% | 7.4% | 5.9% | 31.2% | 0.0% | 0.0x | $857M | VS | |
$TRTNpA Triton International Ltd | 71 | 70 | 89 | 70 | - | 1.7x | 18.0% | 4.6% | 97.3% | 52.2% | 32.7% | -3.4% | 0.0% | 271.0x | $8.0B | VS | |
$EDU New Oriental Education & Technology Group Inc. | 71 | 83 | 52 | 77 | - | - | 9.4% | 4.9% | 55.5% | 8.7% | 7.7% | 13.6% | 1.3% | 7.0x | $78.0B | VS | |
$NTES NetEase, Inc. | 71 | 88 | 93 | 68 | - | - | 22.1% | 15.6% | 62.5% | 28.1% | 28.7% | -1.0% | 2.8% | 9.0x | $56.6B | VS | |
$UTI UNIVERSAL TECHNICAL INSTITUTE INC | 70 | 86 | 86 | 72 | 43.2x | 16.0x | 21.4% | 8.0% | 100.0% | 10.0% | 7.5% | 14.1% | 0.0% | 27.0x | $1.8B | VS | |
$TC TuanChe Ltd | 58 | 52 | 27 | 84 | - | - | 311.3% | -1703.5% | 68.3% | -182.9% | -382.3% | -70.5% | 0.0% | - | $29M | ||
| SECTOR BENCH | - | - | - | - | - | 23.7x | 11.7x | 5.3% | 1.9% | 59.6% | 3.5% | 2.3% | 7.8% | 0.0% | 0.3x | - | REF |
TuanChe Ltd (TC) receives a "Hold" rating with a composite score of 57.7/100. It ranks #934 out of 7,333 stocks in our coverage universe and carries a 3-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
YOY expansion rate
Core pricing power
Operating efficiency
Bottom-line conversion
Equity capital efficiency
Asset base utilization
Direct cash return
Wei Wen
Chief Executive Officer
Labor Force
620
52
61
39
Audit Verdict: Average governance indicators based on financial metrics.
No recent insider transactions available for TC
Outperforming peers — winners tend to keep winning over 3-12 months
Expensive relative to fundamentals — limited margin of safety
Average quality profile
Average volatility — neutral timing signal
Conservative, efficient capex — capital discipline signals management quality
Mid-range overall rating
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Services sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
No analyst ratings for TC.
View All RatingsMaterial decline in asset turnover efficiency detected
High margin volatility — erratic forensic earnings quality
| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 52 | 62 | -10DRAG |
| MOMENTUM | 84 | 93 | -9DRAG |
| VALUATION | 27 | 19 | +8ALPHA |
| INVESTMENT | 61 | 96 | -35DRAG |
| STABILITY | 39 | 35 | +4NEUTRAL |
| SHORT INT | 55 | 66 | -11DRAG |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROIC -200.5% vs WACC 8.6% (spread -209.1%)
GM 68% vs sector 60%, OM -183% vs sector 4%
Capital turnover 1.39x, R&D intensity 24.2%
Rev growth -71%, 7yr history
Interest coverage N/A
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
Our model assigns TuanChe Ltd a Hold rating, with a composite score of 57.7/100 and 3 out of 5 stars. Ranked #934 of 7,333 stocks, TC presents a mixed quantitative picture — neither compelling enough to initiate new positions nor weak enough to warrant selling. Investors already holding may consider maintaining their position while monitoring for changes in the factor profile.
With a quality score of 52/100, TC shows adequate but unremarkable business quality. The company reports a return on equity of 311.3% (sector avg: 5.3%), gross margins of 68.3% (sector avg: 59.6%), net margins of -382.3% (sector avg: 2.3%). This suggests the company generates acceptable returns but may lack the competitive positioning or operational efficiency to stand out from peers.
TC registers a value score of just 27/100, suggesting the stock trades at a significant premium to its fundamental metrics. High-premium valuations like this require strong future execution to avoid multiple compression, and downside risk is elevated if growth disappoints.
TC shows a solid investment score of 61/100, reflecting measured but productive capital allocation. Key growth metrics include revenue growth of -70.5% vs. a sector average of 7.8% and a return on assets of -1703.5% (sector: 1.9%). This suggests the company is investing at an appropriate level to sustain growth without overextending its balance sheet.
TC shows strong momentum characteristics with a score of 84/100. The stock has been trending above key moving averages, indicating solid demand from institutional buyers. Revenue growth stands at -70.5% year-over-year, while a beta of -3.51 reflects its sensitivity to broader market moves. This level of momentum typically signals sustained investor confidence and favorable near-term price action.
TC's stability score of 39/100 signals elevated volatility and/or leverage concerns. Key stability metrics include a beta of -3.51. Investors should be prepared for wider-than-average price swings and consider position sizing accordingly to manage portfolio risk.
The short interest score of 55/100 for TC suggests somewhat elevated bearish positioning by institutional traders. Specific risk factors include micro-cap liquidity risk. With a $29M market cap (micro-cap), TuanChe Ltd may experience above-average volatility. Investors should consider whether the short thesis has merit or if it creates a potential short-squeeze opportunity.
TuanChe Ltd is a micro-cap company in the Services sector, ranked #0 of 50 in its sector (100th percentile) and #934 of 7,333 overall (87th percentile). Key comparisons include ROE of 311.3% exceeding the 5.3% sector median and operating margins of -182.9% below the 3.5% sector average. This top-quartile standing reflects exceptional competitive strength relative to Services peers.
While TC currently exhibits a HOLD profile, superior opportunities exist within the SERVICES sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Services Alpha →Quant Factor Profile
Key factor gap
Momentum (84) vs Value (27) — closing this gap could shift the rating.
ROE 5763% ABOVE SECTOR MEDIAN (FAVORABLE)
Gross Margin 15% ABOVE SECTOR MEDIAN (FAVORABLE)
Op. Margin 5311% BELOW SECTOR MEDIAN
AUDIT DATA AS OF DEC 31, 2024 (Q3 FY2024)
We rate TuanChe Ltd (TC) as a Hold with a composite score of 57.7/100 at a current price of $11.72. The stock presents a mixed quantitative picture — neither compelling enough to warrant new accumulation nor weak enough to justify selling for existing holders. Our factors are split, and the overall profile suggests patience is warranted.
The rating is primarily driven by strength in momentum (84th percentile) and investment (61th percentile), which together account for the majority of the composite score. Offsetting weakness in value (27th percentile) and stability (39th percentile) tempers our overall conviction. We assign a No Moat rating (25/100), Medium uncertainty, and Poor capital allocation.
Key items to watch: whether strong momentum is fundamentally supported by revenue trends; the path to profitability; valuation compression risk if growth disappoints. Any material change in these dynamics could warrant a reassessment of our rating. The moat trend is stable, which suggests the competitive landscape is stable for now.
TuanChe Ltd holds a top-quartile position (#0 of 50) within the Services sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 57.7/100 places it at rank #934 in our full 7,333-stock universe. At $29M in market capitalization, TuanChe Ltd is a small-cap player in the Services space, which limits certain scale advantages but may allow for more agile strategic execution.
Despite positive momentum (84th percentile), revenue contraction of -71% creates a divergence between price action and fundamental trajectory. This divergence suggests either that the market is looking through near-term weakness or that technical factors are temporarily inflating the stock. Investors should assess whether the revenue decline reflects cyclical weakness or structural challenges.
The margin cascade tells an important story: gross margins of 68% (+8.7pp vs sector) narrow to operating margins of -183% (-186.4pp vs sector) and net margins of -382.3%, yielding a gross-to-net conversion rate of -560%. The significant margin erosion from gross to net suggests elevated operating expenses, high interest costs, or other structural drags that warrant monitoring.
At a current price of $11.72, TuanChe Ltd is trading at a premium to fundamental value. Our value factor score of 27/100 reflects a composite assessment across multiple valuation metrics including price-to-earnings, price-to-book, EV/EBITDA, and price-to-sales ratios relative to both sector peers and the broader market. The premium valuation implies the market is pricing in significant future growth or quality improvements that are not yet fully reflected in current fundamentals.
The stock currently trades at P/S of 0.9x. We evaluate these multiples in the context of both absolute levels and sector-relative positioning to form our valuation view.
Gross margins of 68% signal strong pricing power and brand/IP advantages — businesses with margins above 40% have historically demonstrated more resilient earnings through economic cycles.
Returns on equity of 311.3% exceed the cost of equity for most companies, indicating genuine shareholder value creation and a reinvestment engine that compounds wealth over time.
Positive momentum (84th percentile) indicates institutional accumulation and favorable technical dynamics that tend to persist in the intermediate term.
Revenue decline of -71% signals business deterioration — declining revenues make it difficult to grow into the current valuation and often precede further negative revisions.
Thin net margins of -382.3% provide limited cushion against cost pressures, competitive pricing, or macroeconomic headwinds — even small changes in costs could swing the company to a loss.
We assign a Medium uncertainty rating to TuanChe Ltd. The stock presents a balanced risk profile: current negative profitability (net margin -382.3%) and below-average price stability (39th percentile). While not risk-free, the core business fundamentals are adequate to withstand moderate economic stress, and the range of potential outcomes around our fair value estimate is manageable.
Specific risk factors that inform our assessment include: current negative profitability (net margin -382.3%); below-average price stability (39th percentile); low beta of -3.51 — while defensive, this may indicate limited upside participation in bull markets. Each of these factors independently widens the distribution of potential outcomes, and in combination they create a risk profile that demands careful position sizing. The stability factor at the 39th percentile and quality factor at the 52th percentile provide a quantitative summary of the overall risk landscape.
Key risk mitigants include: healthy gross margins of 68% provide a buffer against cost pressures. These factors partially offset the identified risks and provide downside protection in adverse scenarios. On balance, the risk-reward profile is favorable for long-term investors.
We rate TuanChe Ltd's capital allocation as Poor. Key concerns include negative profitability, weak asset returns (ROA -1703.5%). Exemplary capital allocators generate ROE above 20% and maintain conservative leverage — TuanChe Ltd significantly underperforms these benchmarks, raising questions about management's ability to create shareholder value.
Investors should scrutinize management's reinvestment decisions and balance sheet trajectory before committing capital. Poor capital allocation often compounds over time: overlevered balance sheets limit strategic flexibility, while low returns on capital destroy shareholder value. We would need to see sustained improvement in profitability metrics and balance sheet discipline before considering an upgrade.
In summary, TuanChe Ltd receives a Hold rating with a composite score of 57.7/100 (rank #934 of 7,333). Our quantitative framework assigns a No Moat (25/100, trend: stable), Medium uncertainty, and Poor capital allocation. The average factor score across quality, value, momentum, stability, and investment is 52/100.
Our analysis supports a neutral stance on TuanChe Ltd. While the quantitative profile is not weak enough to warrant selling, it lacks the multi-factor strength required for a buy recommendation. Existing holders should maintain positions and monitor for catalysts — either fundamental improvement or valuation compression — that would shift the risk-reward balance.
Analysis derived from Blank Capital Research quantitative terminal. For informational purposes only. No trade solicitation. Past performance not indicative of future results. Consult a qualified advisor.
We do not assign TuanChe Ltd a meaningful economic moat, scoring 25/100 on our composite assessment. The ROIC-WACC spread of -209.1% is the primary signal of economic value creation. Current fundamentals do not demonstrate the kind of durable competitive advantages — such as superior returns on invested capital, margin superiority, or reinvestment efficiency — that would protect the company from competitive erosion over the long term. The highest-scoring pillar, margin superiority, reached only 9.8/20.
The strongest moat sources are margin superiority (9.8/20) and reinvestment efficiency (9.1/20). GM 68% vs sector 60%, OM -183% vs sector 4%. Capital turnover 1.39x, R&D intensity 24.2%. These pillars form the core of TuanChe Ltd's competitive identity and are the primary drivers of excess returns in our framework.
Areas of relative weakness include economic value creation (0.4/20) and financial resilience (1.9/20). ROIC -200.5% vs WACC 8.6% (spread -209.1%). Improvement in these areas could meaningfully widen the moat over time, while deterioration would be an early warning of competitive erosion.
Our moat trend assessment is Stable. Multi-year ROIC and operating margin trajectories show neither meaningful improvement nor deterioration, suggesting the competitive position is steady. We expect TuanChe Ltd's moat profile to remain largely unchanged absent a material shift in return on capital or industry dynamics.
Key profit drivers include gross margins of 68% providing a solid profitability foundation, declining revenues (-71%) that pressure the earnings outlook, returns on equity of 311.3% driving shareholder value creation. The margin cascade from 68% gross to -183% operating to -382.3% net reveals the company's cost structure and reinvestment intensity. Our analysis indicates that profit quality is adequate though not exceptional, with the quality factor at the 52th percentile.
The margin profile shows gross margins of 68%, operating margins of -183%, net margins of -382.3%. Return metrics include ROE of 311.3% and ROA of -1703.5%. Relative to the Services sector, gross margins are 8.7 percentage points above the sector median of 60%, and ROE of 311.3% compares to a sector median of 5.3%.
The balance sheet reflects revenue growth of -71%. Overall balance sheet health is adequate for the current business environment.
Above 50MA
37.18%
Net New Highs
+51081

Shares of Rallybio Corporation (NASDAQ: RLYB) rose sharply in today’s pre-market trading after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant individuals at risk of FNAIT. Rallybio shares jumped rose 77.9% to $2.90 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers Rent the Runway, Inc. (NASDAQ: RENT) shares rose 40.8% to $10.42 in pre-market trading after the company reported mixed fourth-quarter financial results and issued guidance. Alpine Immune Sciences, Inc. (NASDAQ: ALPN) gained 36.1% to $64.02 in pre-market trading after Vertex entered into an agreement to acquire the company. TuanChe Limited (NASDAQ: TC) shares gained 24.4% to $2.24 in pre-market trading after falling 8% on Wednesday. Verb Technology Company, Inc. (NASDAQ: VERB) gained 18.5% to $0.2156 in pre-market trading after gaining 4% on Wednesday. Vera Therapeutics, Inc. (NASDAQ: VERA) climbed 13.1% to $47.06 in pre-market trading ...

Shares of Biophytis S.A. (NASDAQ: BPTS) rose sharply in today’s pre-market trading after reporting FY23 results. Biophytis posted a FY23 loss of €0.03 per share, versus a year-ago loss of €0.14 per share, according to data from Benzinga Pro. Biophytis shares jumped 55.2% to $0.4920 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers MyMD Pharmaceuticals, Inc. (NASDAQ: MYMD) shares rose 40% to $3.64 in pre-market trading after jumping 22% on Monday. MediaCo Holding Inc. (NASDAQ: MDIA) shares rose 20.2% to $3.63 in pre-market trading after falling 22% on Monday. On April 4, an SEC filing showed Standard General L.P. reported a 95.2% stake in the company, as of April 1. Destiny Tech100 Inc. (NASDAQ: DXYZ) gained 18.5% to $118.33 in pre-market trading after jumping over 68% on Monday. Addex Therapeutics Ltd (NASDAQ: ADXN) shares gained 17.2% to $25.60 in pre-market trading after jumping around 21% on Monday. Addex Therapeutics and funds affiliated with Perceptive ...

ZIM Integrated Shipping Services Ltd. (NYSE: ZIM) shares rose sharply in today's pre-market trading after Jefferies upgraded the stock from Hold to Buy and raised its price target from $14 to $20. ZIM Integrated Shipping Services shares climbed 9.2% to $14.72 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers NovaBay Pharmaceuticals, Inc. (NYSE: NBY) gained 71.3% to $0.2810 in pre-market trading after gaining around 8% on Friday. NovaBay Pharmaceuticals and Sonoma Pharmaceuticals recently agreed to market Avenova-branded products in the European Union. Spectral AI, Inc. (NASDAQ: MDAI) gained 33.9% to $3.63 in pre-market trading after gaining more than 35% on Friday. BTIG analyst Ryan Zimmerman recently initiated coverage on Spectral AI with a Buy rating and announced a price target of $4. TuanChe Limited (NASDAQ: TC) shares jumped 31.4% to $3.10 in pre-market trading after jumping more than 10% on Friday. Jianzhi Education Technology Group Company Limited (NASDAQ: JZ) gained 24.1% to $0.7818 in pre-market trading. 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP) surged 17.7% to $0.5884 in pre-market trading. 60 Degrees ...

Gainers Leju Holdings Limited (NYSE: LEJU) gained 103.7% to $7.25 in pre-market trading after jumping around 97% on Monday . Hour Loop, Inc. (NASDAQ: HOUR) shares climbed 93.5% to $3.25 in pre-market trading. EF Hutton recently downgraded Hour Loop from Buy to Hold and lowered the price target from $5 to $2. AGBA Group Holding Limited (NASDAQ: AGBA) climbed 80.6% to $3.65 in pre-market trading after dropping over 12% on Monday. Tian Ruixiang Holdings Ltd (NASDAQ: TIRX) gained 75.6% to $3.83 in pre-market trading after jumping around 34% on Monday. Wah Fu Education Group Limited (NASDAQ: WAFU) surged 47.6% to $4.00 in pre-market trading after gaining 27% on Monday. Huize Holding Limited (NASDAQ: HUIZ) gained 42.4% to $2.05 in pre-market trading after gaining over 15% on Monday. CEL-SCI Corporation (NYSE: CVM) jumped 31.4% ...

Gainers Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) shares surged 179.3% to $2.4585 after the company announced that it has entered into a license agreement for the development and commercialization of INOpulse with Baylor BioSciences. ABVC BioPharma, Inc. (NASDAQ: ABVC) gained 129% to $1.4200 after the company announced the FDA approved its IND submission, allowing the company to proceed with the clinical study of ABV-1519 for the treatment of non-small cell lung cancer. AMTD Digital Inc. (NYSE: HKD) shares jumped 101% to $20.14. Vyant Bio, Inc. (NASDAQ: VYNT) shares rose 59% to $1.2309 after the company said it has engaged LifeSci Capital as its advisor to explore strategic alternatives. Mobiquity Technologies, Inc. (NASDAQ: MOBQ) surged 59% to $1.0350. Mobiquity completed financing to help fund the launch of new publisher focused platform for monetization and compliance. NovoCure Limited (NASDAQ: NVCR) gained 51.8% to $107.04 after the company announced the LUNAR study met its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement in overall survival over standard therapies alone. Zai Lab Limited (NASDAQ: ZLAB) shares gained 42.1% to $48.19 after the company announced the LUNAR study met its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement in overall survival over standard therapies alone. Magic Empire Global Limited (NASDAQ: MEGL) jumped 42% to $1.8786. Rockley Photonics Holdings Limited (NYSE: RKLY) surged 34.6% to $0.2013. Addentax Group Corp. (NASDAQ: ATXG) gained 32% to $1.5700. Arbor Rapha Capital Bioholdings Corp. I (NASDAQ: ARCK) rose 31% to $15.24. Golden Matrix Group, Inc. (NASDAQ: GMGI) gained 26.8% to $3.4238. Ryvyl Inc. (NASDAQ: RVYL) jumped 23% to $0.6894. Jianzhi Education Technology Group Company Limited (NASDAQ: JZ) gained 22% to $0.9376. Orchard Therapeutics plc (NASDAQ: ORTX) jumped 21.5% to $0.6260 after the company announced FDA clearance of the IND application for OTL-203 in MPS-IH. Moxian (BVI) Inc (NASDAQ: MOXC) gained 18.8% to $0.63. Argo Blockchain plc (NASDAQ: ARBK) rose 18.3% to $1.42. Roth Capital, on Wednesday, upgraded Argo ...